These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1731049)

  • 1. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
    Tejani-Butt SM
    J Pharmacol Exp Ther; 1992 Jan; 260(1):427-36. PubMed ID: 1731049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Castration differentially alters [3H]nisoxetine binding to norepinephrine uptake sites in olfactory bulb and frontal cortex of male rats.
    Shang Y; Boja JW; Dluzen DE
    Synapse; 1999 Mar; 31(4):250-5. PubMed ID: 10051105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain.
    Tejani-Butt SM; Brunswick DJ; Frazer A
    Eur J Pharmacol; 1990 Nov; 191(2):239-43. PubMed ID: 2086242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of (R)-[3H]tomoxetine and (R/S)-[3H]nisoxetine binding in rat brain.
    Gehlert DR; Schober DA; Gackenheimer SL
    J Neurochem; 1995 Jun; 64(6):2792-800. PubMed ID: 7760060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
    Reith ME; Wang LC; Dutta AK
    J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]nisoxetine--a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments.
    Cheetham SC; Viggers JA; Butler SA; Prow MR; Heal DJ
    Neuropharmacology; 1996 Jan; 35(1):63-70. PubMed ID: 8684598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine transporters in rat placenta labeled with [3H]nisoxetine.
    Shearman LP; Meyer JS
    J Pharmacol Exp Ther; 1998 Feb; 284(2):736-43. PubMed ID: 9454822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labeling in vivo of serotonin uptake sites in rat brain after administration of [3H]cyanoimipramine.
    Wolfe J; Kreider MS; Goodman C; Brunswick DJ
    J Pharmacol Exp Ther; 1987 Apr; 241(1):196-203. PubMed ID: 3572782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
    Belej T; Manji D; Sioutis S; Barros HM; Nobrega JN
    Brain Res; 1996 Oct; 736(1-2):287-96. PubMed ID: 8930335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain.
    Hipólide DC; Moreira KM; Barlow KB; Wilson AA; Nobrega JN; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):297-303. PubMed ID: 15694238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
    Mash DC; Ouyang Q; Qin Y; Pablo J
    J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
    Nasseri A; Minneman KP
    Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study.
    Strazielle C; Lalonde R; Hébert C; Reader TA
    Neuroscience; 1999; 94(1):287-304. PubMed ID: 10613519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]desipramine binding to rat brain tissue: binding to both noradrenaline uptake sites and sites not related to noradrenaline neurons.
    Bäckström IT; Ross SB; Marcusson JO
    J Neurochem; 1989 Apr; 52(4):1099-106. PubMed ID: 2647903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography.
    Appel NM; Mitchell WM; Contrera JF; De Souza EB
    Synapse; 1990; 6(1):33-44. PubMed ID: 2144664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age on [3H]nisoxetine binding to uptake sites for norepinephrine in the locus coeruleus of humans.
    Tejani-Butt SM; Ordway GA
    Brain Res; 1992 Jun; 583(1-2):312-5. PubMed ID: 1504838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.